Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Lee, TJ; Santeford, A; Pitts, KM; Ripoll, CV; Terao, R; Guo, Z; Ozcan, M; Kratky, D; Christoffersen, C; Javaheri, A; Apte, RS.
Apolipoprotein M attenuates age-related macular degeneration phenotypes via sphingosine-1-phosphate signaling and lysosomal lipid catabolism.
Nat Commun. 2025; 16(1):5331 Doi: 10.1038/s41467-025-60830-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Co-authors Med Uni Graz: Kratky Dagmar
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: Age-related macular degeneration (AMD) is a leading cause of blindness in people over 50. AMD and cardiovascular disease share risk factors including age, impaired lipid metabolism, and extracellular lipid deposition. Because of its importance in age-related diseases, we hypothesize that apolipoprotein M (ApoM), a lipocalin that binds sphingosine-1-phosphate (S1P), might restore lipid homeostasis and retinal function in AMD. In support, we find that human patients with AMD demonstrate significantly reduced ApoM compared to controls. In mice with impaired retinal cholesterol efflux, ApoM improves retinal pigment epithelium (RPE) function and lipotoxicity in an S1P- and S1P receptor 3-dependent manner. Ultrastructural evidence of enhanced melanosome-lipid droplet interactions led us to hypothesize and demonstrate that ApoM-S1P signaling drives RPE-specific lysosomal lipid catabolism. RPE-specific knockout of lysosomal acid lipase recapitulates features of AMD. Our study defines a novel role for ApoM/S1P signaling in AMD driven by RPE lipotoxicity, mediated by cell-autonomous lysosomal lipid catabolism.
Find related publications in this database (using NLM MeSH Indexing): Lysophospholipids - metabolism; Macular Degeneration - metabolism, pathology, genetics; Animals - administration & dosage; Sphingosine - analogs & derivatives, metabolism; Apolipoproteins M - metabolism, genetics; Humans - administration & dosage; Lysosomes - metabolism; Retinal Pigment Epithelium - metabolism, pathology; Signal Transduction - administration & dosage; Lipid Metabolism - administration & dosage; Mice - administration & dosage; Mice, Knockout - administration & dosage; Male - administration & dosage; Female - administration & dosage; Phenotype - administration & dosage; Mice, Inbred C57BL - administration & dosage; Cholesterol - metabolism; Aged - administration & dosage